Published October 5, 2010
| Version v1
Patent
Open
Methods for predicting irinotecan toxicity
Creators
- 1. University of Chicago
Contributors
Patent applicant:
Description
The present invention concerns the methods and compositions for evaluating the risk of ironotecan toxicity in a cancer patient based on the genotype of the patient at position −3156 of the UGT1A1 gene or at any position in linkage disequilibrium with the −3156 variant.
Files
US7807350.pdf
Files
(2.2 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:742053097f3356849d6eb0d7eba49cbc
|
2.2 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 55851004 A
- Patent number
- US 7807350 B2
- Other
- oai:uchicago.tind.io:8179
Dates
- Patent filed
-
2004-05-28